VEON Commences its Delisting from Euronext Amsterdam to Consolidate its Trading on Nasdaq in New York
October 21 2024 - 1:00PM
Amsterdam and Dubai, 21 October
2024: VEON Ltd. (Nasdaq: VEON; Euronext
Amsterdam: VEON), a global digital operator (“VEON” or the
“Company”), today announces that it has commenced the process for
the delisting of its common shares from trading on Euronext
Amsterdam (the “Euronext Amsterdam Delisting”), following the
approval of Euronext Amsterdam. The Company’s last day of trading
on Euronext Amsterdam will be 22 November 2024 (the “Last Trading
Date”) and the delisting will be effective from 25 November
2024.
With this move, VEON will consolidate the trading of its shares
on the Nasdaq Capital Market (“Nasdaq”), which will be the platform
for the trading of VEON’s American depositary shares, each
representing 25 Common Shares (the “ADSs”). Following the Last
Trading Date, all public trading of equity securities in the
Company will take place on Nasdaq under ticker symbol VEON.
“Our decision to consolidate our trading on Nasdaq aligns with
our long-term strategy and the best interests of our investors.
This move will strengthen VEON’s liquidity and simplify our
reporting processes,” said Kaan Terzioglu, VEON Group
CEO. “VEON’s continued listing on Nasdaq, combined with
our recently announced plan to relocate our headquarters, which
will make us the largest Nasdaq-listed company headquartered in
Dubai, underscores our strategic commitment to lead the way for
investors seeking growth in frontier markets.”
VEON is committed to ensuring a smooth and equitable transition
for its Euronext Amsterdam shareholders. On or before the Last
Trading Date, shareholders that do not hold a number of Common
Shares corresponding to a multiple of 25 can sell or purchase
Common Shares so that they hold a number of Common Shares that is a
precise multiple of 25, allowing for the issue of the corresponding
number of ADSs.
The Company is also providing an opportunity for shareholders to
deposit their Common Shares with the Company’s depositary, The Bank
of New York Mellon, in exchange for delivery of ADSs. For those
shareholders who deposit their Common Shares during the period from
the day after the date of this announcement through the Last
Trading Date, the Company will pay the ADS issuance fees.
Existing holders of ADSs not also holding Common
Shares on Euronext Amsterdam do not need to take any action in
relation to the Euronext Amsterdam Delisting.
VEON investors can access further information on the delisting
process on VEON’s website: www.veon.com/investors.
About VEONVEON is a digital
operator that provides converged connectivity and digital services
to nearly 160 million customers. Operating across six countries
that are home to more than 7% of the world’s population, VEON is
transforming lives through technology-driven services that empower
individuals and drive economic growth. VEON is listed on Nasdaq and
Euronext. For more information
visit: https://www.veon.com.
Disclaimer This
announcement contains inside information as defined for the
purposes of Article 7 of Regulation (EU) no. 596/2014 (MAR).
This announcement shall not constitute an offer
to sell or the solicitation of an offer to buy the Common Shares or
ADSs, nor shall there be any sale of the Common Shares or ADSs in
any jurisdiction in which such offer, solicitation or sale would be
unlawful prior to registration or qualification under the
securities laws of any such jurisdiction. The securities described
in this announcement have not been registered under the Securities
Act and may not be offered or sold in the United States absent
registration or an applicable exemption from, or in a transaction
not subject to, the registration requirements.
This announcement does not form part of an offer
of transferable securities to the public in the Netherlands and no
prospectus has been, or is required to be, submitted to the AFM for
approval.
Forward-looking statements
This release contains “forward-looking
statements”, as the phrase is defined in Section 27A of the U.S.
Securities Act of 1933, as amended, and Section 21E of the U.S.
Securities Exchange Act of 1934, as amended. Forward-looking
statements are not historical facts, and include statements
relating to, among other things, the Company’s Euronext Amsterdam
Delisting timetable, its expectations regarding future regulatory
filings and the anticipated trading volume that may result from the
Euronext Amsterdam Delisting. Forward-looking statements are
inherently subject to risks and uncertainties, many of which VEON
cannot predict with accuracy and some of which VEON might not even
anticipate, including the important factors discussed under the
caption Risk Factors in VEON’s annual report on Form 20-F for the
year ended 31 December 2023, which is on file with the U.S.
Securities and Exchange Commission (SEC) and is available on the
SEC website at www.sec.gov. The forward-looking statements
contained in this release speak only as of the date of this
release. VEON does not undertake to publicly update, except as
required by U.S. federal securities laws, any forward-looking
statement to reflect events or circumstances after such dates or to
reflect the occurrence of unanticipated events. There can be no
assurance that the initiatives referred to above will be
successful.
Contact Information:
Hande AsikGroup Director of Strategy and
Communication pr@veon.com
Faisal GhoriGroup Director of Investor Relationsir@veon.com
VEON (NASDAQ:VEON)
Historical Stock Chart
From Oct 2024 to Nov 2024
VEON (NASDAQ:VEON)
Historical Stock Chart
From Nov 2023 to Nov 2024